塞栓療法の世界市場レポート 2025年

塞栓療法市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.9％で68億3,000万米ドルに成長します。予測期間中の成長は、可処分所得の増加、慢性疾患の有病率の増加、生殖医療における塞栓療法採用の増加、化学塞栓術の件数の増加、肝臓がんの罹患率の増加に起因しています。予測期間における主要動向としては、最先端技術の発展、デジタルとアナログ機器の開発、挿入型心臓モニターの使用、塞栓療法技術の革新、戦略的提携などが挙げられます。

低侵襲手術への嗜好の高まりが塞栓療法市場の拡大を牽引すると予想されます。低侵襲治療には、外科的介入をほとんど必要としない美容・医療治療が含まれ、回復時間の短縮、痛みの軽減、傷跡の縮小、合併症リスクの低減、技術の進歩による精度の向上などの利点があります。塞栓療法は、対象とする血管への血流を選択的に遮断し、出血を抑え、腫瘍を治療し、血管の異常をより正確に、より少ない合併症で管理することで、低侵襲性処置をサポートします。例えば、2023年9月、米国の非営利団体である米国形成外科学会（American Society of Plastic Surgeons）は、美容目的の低侵襲手術が2023年に7％増加し、2022年の23,672,269件から25,442,640件に達したと報告しました。その結果、低侵襲処置への嗜好の高まりが塞栓療法市場の成長を後押ししています。

塞栓療法市場の主要企業は、患者の予後を改善し治療の選択肢を広げるため、吸収性塞栓システムなどの革新的ソリューションの開発に注力しています。吸収性塞栓システムは、腫瘍や動脈瘤などの標的組織への血流を遮断する塞栓術に使用される生体吸収性材料であり、時間の経過とともに体内で徐々に分解されます。例えば、2025年1月、米国の医療機器メーカーであるInstylla Inc.は、85～255μmの不規則な形態のドライゼラチン粒子からなる生体吸収性塞栓剤であるTembo塞栓システムの米国食品医薬品局（FDA）510（k）認可を取得しました。このシステムは、多血性腫瘍を塞栓し、末梢血管系の血管を閉塞するように設計されています。Instyllaによると、Temboは、簡単な準備、高い視認性、治療血管を密に詰める能力などの利点を提供し、既存の永久的塞栓ソリューションを改善する可能性があるといいます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の塞栓療法PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の塞栓療法市場：成長率分析
• 世界の塞栓療法市場の実績：規模と成長、2019～2024年
• 世界の塞栓療法市場の予測：規模と成長、2024～2029年、2034年
• 世界の塞栓療法総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の塞栓療法市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 塞栓コイル
• 塞栓剤
• 脱着式バルーン
• 塞栓プラグシステム
• サポートデバイス
• 世界の塞栓療法市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 腫瘍学
• 末梢血管疾患
• 泌尿器科と腎臓科
• 神経学
• 胃腸障害
• 世界の塞栓療法市場手順別、実績と予測、2019～2024年、2024～2029年、2034年
• 経カテーテル動脈塞栓術（TAE）
• 経カテーテル動脈放射線塞栓術（TARE）または選択的内部放射線療法（SIRT）
• 経動脈化学塞栓術（TACE）
• 世界の塞栓療法市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 外来手術センター
• 病院とクリニック
• その他
• 世界の塞栓療法市場、塞栓コイルのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ベアコイル
• コーティングコイル
• マイクロコイル
• 世界の塞栓療法市場、塞栓剤のサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 液体塞栓剤
• 粒子状塞栓剤
• ゼラチンスポンジ
• ポリビニルアルコール（PVA）粒子
• 世界の塞栓療法市場、脱着式バルーンのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 使い捨てバルーン
• 多目的バルーン
• 世界の塞栓療法市場、塞栓プラグシステムのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• プラグキット
• 遠位閉塞システム
• 世界の塞栓療法市場、サポートデバイスのサブセグメンテーション、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ガイドワイヤ
• カテーテル
• シースイントロデューサー

第7章 地域別・国別分析

• 世界の塞栓療法市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の塞栓療法市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 塞栓療法市場：競合情勢
• 塞栓療法市場：企業プロファイル
  • Boston Scientific Corporation
  • Terumo Medical Corporation
  • Medtronic PLC
  • Johnson And Johnson
  • Stryker Corporation

第31章 その他の大手企業と革新的企業

• Sirtex Medical
• Abbott Laboratories
• Acandis GmbH
• Balt Group LLC
• Penumbra Inc
• Merit Medical Systems
• Kaneka Corporation
• Meril Life Sciences Pvt. Ltd.
• Shape Memory Medical Inc
• Guerbet
• IMBIoTechnologies Ltd
• Cardiva
• Rapid Medical
• Emboline Inc
• Microport Scientific

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• 塞栓療法市場、2029年：新たな機会を提供する国
• 塞栓療法市場、2029年：新たな機会を提供するセグメント
• 塞栓療法市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Embolotherapy is a minimally invasive medical procedure that involves deliberately blocking blood vessels to treat various conditions. This is achieved by injecting embolic agents such as microspheres, coils, gels, or liquid embolics into targeted blood vessels, cutting off the blood supply to abnormal tissues or structures. As a highly targeted alternative to traditional surgery, embolotherapy is typically performed by interventional radiologists, offering improved patient outcomes with minimal recovery time.

The primary product types used in embolotherapy include embolization coils, embolic agents, detachable balloons, embolic plug systems, and support devices. Embolization coils are small, flexible devices designed to block blood flow in targeted vessels, treating conditions such as aneurysms, tumors, and vascular malformations. These products are applied in various medical fields, including oncology, peripheral vascular diseases, urology and nephrology, neurology, and gastrointestinal (GIT) disorders. Embolotherapy procedures include transcatheter arterial embolization (TAE), transcatheter arterial radioembolization (TARE) or selective internal radiation therapy (SIRT), and transarterial chemoembolization (TACE). The key end users of embolotherapy products include ambulatory surgical centers, hospitals, clinics, and other healthcare providers.

The embolotherapy market research report is one of a series of new reports from The Business Research Company that provides embolotherapy market statistics, including the embolotherapy industry global market size, regional shares, competitors with the embolotherapy market share, detailed embolotherapy market segments, market trends, and opportunities, and any further data you may need to thrive in the embolotherapy industry. This embolotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The embolotherapy market size has grown strongly in recent years. It will grow from $4.44 billion in 2024 to $4.86 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth during the historic period can be attributed to the rising demand for embolotherapy in treatment, the increasing incidence of cancer and peripheral vascular diseases, growing healthcare expenditure, and higher investment in research.

The embolotherapy market size is expected to see strong growth in the next few years. It will grow to $6.83 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth during the forecast period can be attributed to rising disposable income, the increasing prevalence of chronic diseases, the growing adoption of embolotherapy in reproductive health, the rising number of chemoembolization procedures, and the increasing incidence of liver cancer. Key trends in the forecast period include advancements in cutting-edge technologies, the development of digital and analog devices, the use of insertable cardiac monitors, innovations in embolotherapy techniques, and strategic collaborations.

The growing preference for minimally invasive procedures is expected to drive the expansion of the embolotherapy market. Minimally invasive procedures involve cosmetic and medical treatments that require little to no surgical intervention, offering benefits such as reduced recovery time, less pain, smaller scars, lower risks of complications, and improved precision due to technological advancements. Embolotherapy supports minimally invasive procedures by selectively blocking blood flow to targeted vessels, reducing bleeding, treating tumors, and managing vascular abnormalities with greater accuracy and fewer complications. For instance, in September 2023, the American Society of Plastic Surgeons, a US-based non-profit organization, reported that cosmetic minimally invasive procedures increased by 7% in 2023, reaching 25,442,640 treatments, up from 23,672,269 in 2022. As a result, the increasing preference for minimally invasive procedures is fueling the growth of the embolotherapy market.

Leading companies in the embolotherapy market are focusing on developing innovative solutions, such as absorbable embolic systems, to enhance patient outcomes and expand treatment options. Absorbable embolic systems are bioresorbable materials used in embolization procedures to block blood flow to targeted tissues, such as tumors or aneurysms, while gradually degrading within the body over time. For example, in January 2025, Instylla Inc., a US-based medical equipment manufacturer, received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Tembo embolic system, a bioresorbable embolization agent made of irregularly shaped, dry-gelatin particles sized between 85 and 255 µm. The system is designed to embolize hypervascular tumors and occlude blood vessels in the peripheral vasculature. According to Instylla, Tembo offers advantages such as easy preparation, high visibility, and the ability to densely pack treated vessels, potentially improving upon existing permanent embolic solutions.

In November 2024, Merit Medical Systems Inc., a US-based healthcare technology company, acquired the Lead Management Portfolio from Cook Medical for approximately $210 million. This acquisition aims to strengthen Merit Medical Systems' electrophysiology (EP) and cardiac rhythm management (CRM) business by expanding its product portfolio and market reach. Cook Medical LLC is a US-based medical device company specializing in embolization coils.

Major players in the embolotherapy market are Boston Scientific Corporation, Terumo Medical Corporation , Medtronic PLC, Johnson And Johnson, Stryker Corporation, Sirtex Medical, Abbott Laboratories, Acandis GmbH, Balt Group LLC, Penumbra Inc, Merit Medical Systems, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Shape Memory Medical Inc, Guerbet, IMBiotechnologies Ltd, Cardiva , Rapid Medical, Emboline Inc, Microport Scientific, Inari Medical, Instylla Inc, Embolx Inc, GE Healthcare, Lepu Medical Technology Co Ltd, WEGO HEALTHCARE (SHENZHEN) CO., LTD, Achieva Medical Inc, Varian Medical Syatems Inc.

North America was the largest region in the embolotherapy market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in embolotherapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the embolotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The embolotherapy market consists of revenues earned by entities by providing services such as catheter-based embolization, flow diversion therapy, tumor embolization, uterine fibroid embolization, and endovenous embolization for varicose veins. The market value includes the value of related goods sold by the service provider or included within the service offering. The embolotherapy market also includes sales of microcatheters, liquid embolic agents, particle embolic agents, balloon occlusion devices, and flow diverters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Embolotherapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on embolotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for embolotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The embolotherapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Embolization Coil; Embolic Agents; Detachable Balloons; Embolic Plug Systems; Support Devices
• 2) By Application: Oncology; Peripheral Vascular Diseases; Urology and Nephrology; Neurology; Gastrointestinal (GIT) Disorders
• 3) By Procedure: Transcatheter Arterial Embolization (TAE); Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT); Transarterial Chemoembolization (TACE)
• 4) By End User: Ambulatory Surgical Centre; Hospitals And Clinics; Other End Users
• Subsegments:
• 1) By Embolization Coil: Bare Coils; Coated Coils; Micro Coils
• 2) By Embolic Agents: Liquid Embolic Agents; Particulate Embolic Agents; Gelatin Sponge; Polyvinyl Alcohol (PVA) Particles
• 3) By Detachable Balloons: Single-Use Balloons; Multi-Use Balloons
• 4) By Embolic Plug Systems: Plug Kits; Distal Occlusion Systems
• 5) By Support Devices: Guidewires; Catheters; Sheath Introducers
• Companies Mentioned: Boston Scientific Corporation; Terumo Medical Corporation ; Medtronic PLC; Johnson And Johnson; Stryker Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Embolotherapy Market Characteristics

3. Embolotherapy Market Trends And Strategies

4. Embolotherapy Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Embolotherapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Embolotherapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Embolotherapy Market Growth Rate Analysis
• 5.4. Global Embolotherapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Embolotherapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Embolotherapy Total Addressable Market (TAM)

6. Embolotherapy Market Segmentation

• 6.1. Global Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Embolization Coil
• Embolic Agents
• Detachable Balloons
• Embolic Plug Systems
• Support Devices
• 6.2. Global Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Peripheral Vascular Diseases
• Urology and Nephrology
• Neurology
• Gastrointestinal (GIT) Disorders
• 6.3. Global Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transcatheter Arterial Embolization (TAE)
• Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT)
• Transarterial Chemoembolization (TACE)
• 6.4. Global Embolotherapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ambulatory Surgical Centre
• Hospitals And Clinics
• Other End Users
• 6.5. Global Embolotherapy Market, Sub-Segmentation Of Embolization Coil, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bare Coils
• Coated Coils
• Micro Coils
• 6.6. Global Embolotherapy Market, Sub-Segmentation Of Embolic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Embolic Agents
• Particulate Embolic Agents
• Gelatin Sponge
• Polyvinyl Alcohol (PVA) Particles
• 6.7. Global Embolotherapy Market, Sub-Segmentation Of Detachable Balloons, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Use Balloons
• Multi-Use Balloons
• 6.8. Global Embolotherapy Market, Sub-Segmentation Of Embolic Plug Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plug Kits
• Distal Occlusion Systems
• 6.9. Global Embolotherapy Market, Sub-Segmentation Of Support Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Guidewires
• Catheters
• Sheath Introducers

7. Embolotherapy Market Regional And Country Analysis

• 7.1. Global Embolotherapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Embolotherapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Embolotherapy Market

• 8.1. Asia-Pacific Embolotherapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Embolotherapy Market

• 9.1. China Embolotherapy Market Overview
• 9.2. China Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Embolotherapy Market

• 10.1. India Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Embolotherapy Market

• 11.1. Japan Embolotherapy Market Overview
• 11.2. Japan Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Embolotherapy Market

• 12.1. Australia Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Embolotherapy Market

• 13.1. Indonesia Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Embolotherapy Market

• 14.1. South Korea Embolotherapy Market Overview
• 14.2. South Korea Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Embolotherapy Market

• 15.1. Western Europe Embolotherapy Market Overview
• 15.2. Western Europe Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Embolotherapy Market

• 16.1. UK Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Embolotherapy Market

• 17.1. Germany Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Embolotherapy Market

• 18.1. France Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Embolotherapy Market

• 19.1. Italy Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Embolotherapy Market

• 20.1. Spain Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Embolotherapy Market

• 21.1. Eastern Europe Embolotherapy Market Overview
• 21.2. Eastern Europe Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Embolotherapy Market

• 22.1. Russia Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Embolotherapy Market

• 23.1. North America Embolotherapy Market Overview
• 23.2. North America Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Embolotherapy Market

• 24.1. USA Embolotherapy Market Overview
• 24.2. USA Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Embolotherapy Market

• 25.1. Canada Embolotherapy Market Overview
• 25.2. Canada Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Embolotherapy Market

• 26.1. South America Embolotherapy Market Overview
• 26.2. South America Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Embolotherapy Market

• 27.1. Brazil Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Embolotherapy Market

• 28.1. Middle East Embolotherapy Market Overview
• 28.2. Middle East Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Embolotherapy Market

• 29.1. Africa Embolotherapy Market Overview
• 29.2. Africa Embolotherapy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Embolotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Embolotherapy Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Embolotherapy Market Competitive Landscape And Company Profiles

• 30.1. Embolotherapy Market Competitive Landscape
• 30.2. Embolotherapy Market Company Profiles
  • 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Terumo Medical Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Embolotherapy Market Other Major And Innovative Companies

• 31.1. Sirtex Medical
• 31.2. Abbott Laboratories
• 31.3. Acandis GmbH
• 31.4. Balt Group LLC
• 31.5. Penumbra Inc
• 31.6. Merit Medical Systems
• 31.7. Kaneka Corporation
• 31.8. Meril Life Sciences Pvt. Ltd.
• 31.9. Shape Memory Medical Inc
• 31.10. Guerbet
• 31.11. IMBiotechnologies Ltd
• 31.12. Cardiva
• 31.13. Rapid Medical
• 31.14. Emboline Inc
• 31.15. Microport Scientific

32. Global Embolotherapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Embolotherapy Market

34. Recent Developments In The Embolotherapy Market

35. Embolotherapy Market High Potential Countries, Segments and Strategies

• 35.1 Embolotherapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Embolotherapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Embolotherapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer